Flamingo Therapeutics
Gaston Geenslaan 3 BLDG 4
3001 Leuven
BE
Flamingo Therapeutics
Foundation date
04/07/2019
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
The core business of Flamingo Therapeutics is the development of novel and innovative drugs for specific cancer types.Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
2 hours ago
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
1 day ago
Read more
-
ExeVir Announces Michael Garrett as New Chief Executive Officer
Tuesday November 19th 2024
Read more
Jobs
More jobs-
-
-
20/11/24
Antwerp
Postdoc position in the Laboratory for Gut-Immune-Brain Axis Research
Permanent
VIB
More info?
Contact us
Ellen Telleir
Communication Coordinator